FIELD: pharmacology.
SUBSTANCE: invention claims novel bioactive compound, lysinium 3-methyl-1,2,4- triasolyl-5-thioacetate.
EFFECT: basis for obtainment of medicines with wide range of bioactivity for treatment of central nervous system diseases, including acute disorders of cerebral blood circulation, and cardiac decompensation.
1 cl, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| CEREBROPROTECTIVE AND NOOTROPIC MEDICINAL AGENT "NOOTRIL" IN ENVELOPE-COVERED TABLET | 2003 |
|
RU2248203C2 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| COMBINED DRUG FOR PHARMACORRECTION OF COGNITIVE DYSFUNCTIONS AFTER KETAMINE ANESTHESIA | 2020 |
|
RU2748035C1 |
| METHOD FOR TREATMENT OF ALCOHOLIC CARDIOMYOPATHY | 2017 |
|
RU2642298C1 |
| COMBINED DRUG OF ANXIOLITHIC, STRESS-PROTECTOR, NOOTROPIC AND ANTIOXIDANT ACTION | 2016 |
|
RU2625754C1 |
| 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (MT) | 2008 |
|
RU2404974C2 |
| METHOD OF TREATING PATIENTS WITH CHRONIC ALCOHOL INTOXICATION | 2014 |
|
RU2566075C1 |
